NCT00699283

A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures

An interim analysis revealed the study was unlikely to attain a positive outcome for the efficacy analysis. No safety concerns were detected